trial · primary record
MK-3120
Bladder Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 45 |
| Primary completion | 2029-02-28 |
| Primary endpoint | Number of Participants Who Experience a Dose-limiting Toxicity (DLT) |
| Registry ID | NCT07222488 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:05.352Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07222488
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Mk-3120 · compound